New treatment option for Nicotine Use Disorder
Official title Implementation of Tobacco Cessation Programming at Community Behavioral Health Sites
ClinicalTrials.gov ID: NCT06837220
What this study is testing
- What it's testing
- The goal of this study is to: partner with Respiratory Health Association and determine barriers and unmet smoking cessation treatment needs from leaders in behavioral health organizations, treatment programs and adults who smoke (AWS) in Chicago. This will be accomplished by establishing a community advisory board (CAB) and pilot testing a community-informed smoking cessation treatment within a community behavioral health organization to determine its feasibility after addressing implementation issues.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 26
You may be able to join if
- Identify as someone who currently smokes combustible cigarettes (at least 1 cigarette per day) on each day for the past month
- Report interest in quitting cigarettes (at least 6/10 scale in interest of quitting)
- Age 18 or older, ability to understand the English language, willing and able to provide informed consent
- Stable residence and contact information throughout the follow up period
You likely can't join if
- Non-daily or intermittent cigarette use
- No interest in quitting smoking
- Unstable residence/not staying in Chicago for duration of study period
- Current untreated severe substance use disorder (with the exception of tobacco use) or past-year serious untreated psychiatric illness (e.g...
The study team makes the final eligibility decision.
Where it's taking place
- Chicago, Illinois, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 26 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chicago, Illinois, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.